Clinical Trial Update: The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of enalapril, losartan, or no antihypertensive therapy on oxidative stress in renal transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Oxidative Stress
• Renal Transplant Recipients

Drugs mentioned

• Enalapril (enalapril)
• Losartan (losartan)

Snippet

Sponsor: Unidad de Investigacion Medica en Enfermedades Renales | Conditions: Oxidative Stress | Phase 2 | Status: COMPLETED